ORIX (TSE:8591) Lifts Dividend Guidance Following Earnings While Fair Value Still Sits Higher

ORIX (TSE:8591) has moved into focus after its board met on 6 August 2026 to revise the dividend policy for the fiscal year ending 31 March 2027, along with releasing fresh earnings and guidance.

See our latest analysis for ORIX.

At a share price of ¥6,294, ORIX has had a firm year to date, with a 36.35% share price return and a 70.19% total shareholder return over 12 months. This suggests momentum has been building as investors respond to stronger guidance, revised dividends and recent write downs.

If this kind of rerating catches your interest, it can be useful to see what else is moving in related areas and check out 12 top founder-led companies

ORIX now combines a broad financial services footprint with richer dividend guidance and a strong recent share price run. The key issue for you is whether that quality is already fully reflected in the ¥6,294 price.

Most Popular Narrative: 5.8% Undervalued

ORIX is trading at ¥6,294 against a most widely followed fair value estimate of ¥6,678.89, which frames the recent dividend and buyback moves in a valuation context.

The company is leveraging the global increase in demand for alternative and private capital, as seen by robust inflows at Robeco and strong growth in third-party AUM (¥81 trillion, up ¥7 trillion in three months), pointing to a secular shift towards sustainable fee-based revenue and improving margins.

Read the complete narrative.

Want to see what sits behind that fair value for ORIX? The narrative leans heavily on fee income, higher margins and a specific profit path. It is worth examining which earnings and share count assumptions really move the valuation.

Result: Fair Value of ¥6,678.89 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ORIX still faces two clear pressure points: reliance on one-off asset gains and the risk that higher interest rates continue to weigh on core lending and private equity.

Find out about the key risks to this ORIX narrative.

Next Steps

With ORIX presenting both clear risks and appealing rewards, the balance of sentiment is mixed. Move quickly and shape your own view by checking the 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond ORIX?

If ORIX has sharpened your focus, now is the moment to widen your watchlist with other clear, data backed opportunities that could fit your goals.

• Target reliable income by scanning companies built around robust payouts and consistent cash flows using the 34 dividend fortresses
• Hunt for quality at a sensible price by checking companies that screen well on valuation and fundamentals through the 26 high quality undervalued stocks
• Reduce downside risk by focusing on companies with stronger balance sheets and healthier financial profiles in the solid balance sheet and fundamentals stocks screener (41 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com